{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:18:00Z","timestamp":1790957880498,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360394"],"award-info":[{"award-number":["82360394"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460399"],"award-info":[{"award-number":["82460399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.intimp.2025.114693","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T12:23:47Z","timestamp":1745929427000},"page":"114693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The role of notch signaling in regulating myeloid-derived suppressor cells: Implications in Cancer and autoimmune diseases"],"prefix":"10.1016","volume":"157","author":[{"given":"Huidong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114693_bb0005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114693_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112949","article-title":"Myeloid-derived suppressor cells in cancer: current knowledge and future perspectives","volume":"142","author":"Rajkumari","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114693_bb0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.114693_bb0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.intimp.2011.01.026","article-title":"MDSC in autoimmunity","volume":"11","author":"Cripps","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114693_bb0025","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s10787-021-00846-3","article-title":"Role of myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target","volume":"29","author":"Nourbakhsh","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2025.114693_bb0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.18632\/oncotarget.28303","article-title":"Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more","volume":"13","author":"Shibata","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2025.114693_bb0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.114693_bb0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","article-title":"Notch signaling in the tumor microenvironment","volume":"34","author":"Meurette","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2025.114693_bb0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood-2007-05-087353","article-title":"Targeting notch signaling in autoimmune and lymphoproliferative disease","volume":"111","author":"Teachey","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.114693_bb0050","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230893","article-title":"Transcriptional network dynamics in early T cell development","volume":"221","author":"Shin","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.114693_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0065","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41419-022-05080-5","article-title":"Monocytic myeloid-derived suppressive cells mitigate over-adipogenesis of bone marrow microenvironment in aplastic anemia by inhibiting CD8+ T cells","volume":"13","author":"Qu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.114693_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion","volume":"13","author":"Lu","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.114693_bb0075","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00262-018-2245-6","article-title":"The role of CCR5 in directing the mobilization and biological function of CD11b+Gr1+Ly6Clow polymorphonuclear myeloid cells in cancer","volume":"67","author":"Karin","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2025.114693_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/nyas.12469","article-title":"Myeloid-derived suppressor cell heterogeneity in human cancers","volume":"1319","author":"Solito","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2025.114693_bb0085","doi-asserted-by":"crossref","first-page":"1161848","DOI":"10.3389\/fimmu.2023.1161848","article-title":"Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis","volume":"14","author":"Glover","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0090","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3389\/fphar.2020.00576","article-title":"Apolipoprotein A-I mimetic peptide L-4F suppresses granulocytic-myeloid-derived suppressor cells in mouse pancreatic Cancer","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114693_bb0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00011-019-01237-9","article-title":"Adoptive transfer of IFN-\u03b3-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathway","volume":"68","author":"Yang","year":"2019","journal-title":"Inflamm Res: Off J Eur Histamine Res Soc [et Al,]."},{"key":"10.1016\/j.intimp.2025.114693_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2007-04-086835","article-title":"Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function","volume":"111","author":"Pan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.114693_bb0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fimmu.2018.00978","article-title":"Targeting VEGF\/VEGFR to modulate antitumor immunity","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/dvdy.339","article-title":"Transforming growth factor-beta1 and myeloid-derived suppressor cells: a cancerous partnership","volume":"251","author":"Mojsilovic","year":"2022","journal-title":"Dev Dyn: Off Publ Am Assoc Anat."},{"key":"10.1016\/j.intimp.2025.114693_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.2023022738","article-title":"Platelet-derived TGF-\u03b21 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia","volume":"144","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.114693_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12915-024-01876-3","article-title":"Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway","volume":"22","author":"Zhang","year":"2024","journal-title":"BMC Biol."},{"key":"10.1016\/j.intimp.2025.114693_bb0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/cgt.2016.19","article-title":"Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases","volume":"23","author":"Thorn","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2025.114693_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109746","article-title":"Synergic effect of PD-1 blockade and endostar on the PI3K\/AKT\/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model. Biomed Pharmacother =","volume":"125","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114693_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1535-7163.MCT-18-0464","article-title":"Urolithin a, a novel natural compound to target PI3K\/AKT\/mTOR pathway in pancreatic cancer","volume":"18","author":"Totiger","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2025.114693_bb0140","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/ijc.27974","article-title":"Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells","volume":"132","author":"Hong","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2025.114693_bb0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10637-022-01218-6","article-title":"Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells","volume":"40","author":"Wang","year":"2022","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.intimp.2025.114693_bb0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4110\/in.2017.17.3.144","article-title":"TLR\/MyD88-mediated innate immunity in intestinal graft-versus-host disease","volume":"17","author":"Lee","year":"2017","journal-title":"Immune Netw."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2025.114693_bb0155","first-page":"1","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2025.114693_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcimb.2016.00037","article-title":"Myeloid-derived suppressor cells in bacterial infections","volume":"6","author":"Ost","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2025.114693_bb0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0180","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.0903275","article-title":"Tim-3\/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells","volume":"185","author":"Dardalhon","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0185","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1564505","article-title":"Tim-3\/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients","volume":"8","author":"Limagne","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2025.114693_bb0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41389-020-00248-0","article-title":"Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.intimp.2025.114693_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119627","article-title":"Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives","volume":"277","author":"Mortezaee","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114693_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606024","article-title":"Programmed death-ligand 1 expression potentiates the immune modulatory function of myeloid-derived suppressor cells in systemic lupus erythematosus","volume":"12","author":"Park","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0205","doi-asserted-by":"crossref","first-page":"39296","DOI":"10.1038\/srep39296","article-title":"PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment","volume":"6","author":"Iwata","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114693_bb0210","doi-asserted-by":"crossref","first-page":"1516421","DOI":"10.3389\/fcimb.2024.1516421","article-title":"Polymorphonuclear myeloid-derived suppressor cells regulates immune recovery during HIV infection through PD-L1 and TGF-\u03b2 pathways","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2025.114693_bb0215","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/s41467-024-50754-7","article-title":"Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade (15 words)","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114693_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790317","article-title":"Siglec signaling in the tumor microenvironment","volume":"12","author":"van Houtum","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0225","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41423-024-01142-0","article-title":"Engagement of sialylated glycans with siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2","volume":"21","author":"Wieboldt","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/2326-6066.CIR-13-0016","article-title":"Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production","volume":"1","author":"De Coa\u00f1a","year":"2013","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2025.114693_bb0235","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.4049\/jimmunol.1101225","article-title":"Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells","volume":"187","author":"Ryzhov","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2025.114693_bb0245","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2025.114693_bb0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2012.01.011","article-title":"Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression","volume":"22","author":"Ostrand-Rosenberg","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2025.114693_bb0255","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138581","article-title":"Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer","volume":"5","author":"Ugolini","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2025.114693_bb0260","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0265","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.23054","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.114693_bb0270","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.canlet.2015.10.022","article-title":"Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment","volume":"380","author":"Qu","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.114693_bb0275","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4049\/jimmunol.1701069","article-title":"Myeloid-derived suppressor cells impair B cell responses in lung Cancer through IL-7 and STAT5","volume":"201","author":"Wang","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0280","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1413520","article-title":"A novel MDSC-induced PD-1-PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties","volume":"7","author":"Shen","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2025.114693_bb0285","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17375","article-title":"Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes","volume":"5","author":"Ku","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.intimp.2025.114693_bb0290","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tcb.2015.07.010","article-title":"Ligand-independent mechanisms of notch activity","volume":"25","author":"Palmer","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.intimp.2025.114693_bb0295","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220004","article-title":"Notch signalling in healthy and diseased vasculature","volume":"12","author":"Del Gaudio","year":"2022","journal-title":"Open Biol."},{"key":"10.1016\/j.intimp.2025.114693_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.114693_bb0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/BST20200782","article-title":"Glycans that regulate notch signaling in the intestine","volume":"50","author":"Nauman","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.intimp.2025.114693_bb0310","doi-asserted-by":"crossref","first-page":"1078768","DOI":"10.3389\/fonc.2023.1078768","article-title":"Notch signaling, hypoxia, and cancer","volume":"13","author":"Guo","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.114693_bb0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-biophys-101920-082204","article-title":"Biophysics of notch signaling","volume":"50","author":"Sprinzak","year":"2021","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.intimp.2025.114693_bb0320","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mus.27684","article-title":"The notch signaling pathway in skeletal muscle health and disease","volume":"66","author":"Vargas-Franco","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.intimp.2025.114693_bb0325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.114693_bb0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/cells9010111","article-title":"The role of notch signaling in macrophages during inflammation and infection: implication in rheumatoid arthritis?","volume":"9","author":"Keewan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.114693_bb0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s43556-022-00099-8","article-title":"The role of hedgehog and notch signaling pathway in cancer","volume":"3","author":"Xia","year":"2022","journal-title":"Mol Biomed."},{"key":"10.1016\/j.intimp.2025.114693_bb0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41573-020-00091-3","article-title":"Targeting notch in oncology: the path forward","volume":"20","author":"Majumder","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2025.114693_bb0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-22-0243","article-title":"Targeting the DLL\/notch signaling pathway in Cancer: challenges and advances in clinical development","volume":"22","author":"You","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2025.114693_bb0350","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/carcin\/bgt127","article-title":"The notch signaling pathway as a mediator of tumor survival","volume":"34","author":"Capaccione","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.intimp.2025.114693_bb0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-019-0745-2","article-title":"DLL3: an emerging target in small cell lung cancer","volume":"12","author":"Owen","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.114693_bb0360","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ncb3555","article-title":"Dll4 and notch signalling couples sprouting angiogenesis and artery formation","volume":"19","author":"Pitulescu","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2025.114693_bb0365","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1242\/dev.01860","article-title":"Distinct roles for mind bomb, neuralized and epsin in mediating DSL endocytosis and signaling in drosophila","volume":"132","author":"Wang","year":"2005","journal-title":"Dev (Camb Engl)"},{"key":"10.1016\/j.intimp.2025.114693_bb0370","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1242\/dev.01434","article-title":"Fat facets and liquid facets promote delta endocytosis and delta signaling in the signaling cells","volume":"131","author":"Overstreet","year":"2004","journal-title":"Dev (Camb Engl)"},{"key":"10.1016\/j.intimp.2025.114693_bb0375","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1083\/jcb.201105166","article-title":"Distinct intracellular motifs of delta mediate its ubiquitylation and activation by Mindbomb1 and neuralized","volume":"195","author":"Daskalaki","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.intimp.2025.114693_bb0380","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00281-016-0617-6","article-title":"Cancer and autoimmunity","volume":"39","author":"Andersen","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2025.114693_bb0385","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","article-title":"Myeloid suppressor cells in cancer and autoimmunity","volume":"85","author":"Sica","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2025.114693_bb0390","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1158\/0008-5472.CAN-15-2528","article-title":"Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL6\/STAT3 and NO\/NOTCH cross-talk signaling","volume":"76","author":"Peng","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.114693_bb0395","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3389\/fimmu.2018.01288","article-title":"Notch signaling in myeloid cells as a regulator of tumor immune responses","volume":"9","author":"Hossain","year":"2018","journal-title":"Front. Immunol."},{"issue":"186","key":"10.1016\/j.intimp.2025.114693_bb0400","first-page":"4244","article-title":"ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2\/site 3 cleavage products of notch","volume":"2011","author":"Gibb","year":"1950","journal-title":"J Immunol baltim Md"},{"key":"10.1016\/j.intimp.2025.114693_bb0405","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/08916934.2017.1283405","article-title":"Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses","volume":"50","author":"Kontaki","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2025.114693_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242092","article-title":"Myeloid - derived suppressor cells in type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms","volume":"15","author":"Grohov\u00e1","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.114693_bb0415","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clim.2015.02.001","article-title":"Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation","volume":"157","author":"Zhang","year":"2015","journal-title":"Clin Immunol (orlando Fla,)"},{"key":"10.1016\/j.intimp.2025.114693_bb0420","first-page":"1257","article-title":"Role for granulocyte colony-stimulating factor in neutrophilic extramedullary myelopoiesis in a murine model of systemic juvenile idiopathic arthritis. Arthritis","volume":"74","author":"Malengier-Devlies","year":"2022","journal-title":"Rheumatol (hob N.j,)"},{"key":"10.1016\/j.intimp.2025.114693_bb0425","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41419-018-0810-8","article-title":"Suppression of Notch1 and AKT mediated epithelial to mesenchymal transition by verrucarin J in metastatic colon cancer","volume":"9","author":"Pal","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.114693_bb0430","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12885-023-10526-w","article-title":"Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2025.114693_bb0435","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1158\/0008-5472.CAN-05-1069","article-title":"High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival","volume":"65","author":"Reedijk","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.114693_bb0440","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1158\/0008-5472.CAN-15-2528","article-title":"Myeloid-derived suppressor cells endow stem-like qualities to breast Cancer cells through IL6\/STAT3 and NO\/NOTCH cross-talk signaling","volume":"76","author":"Peng","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.114693_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216647","article-title":"Notch signaling and targeted therapy in non-small cell lung cancer","volume":"585","author":"Sun","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.114693_bb0450","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.immuni.2024.03.020","article-title":"Jagged2 targeting in lung cancer activates anti-tumor immunity via notch-induced functional reprogramming of tumor-associated macrophages","volume":"57","author":"Mandula","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114693_bb0455","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood-2007-12-130096","article-title":"NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL","volume":"112","author":"Sulis","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.114693_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.809261","article-title":"Notch-signaling deregulation induces myeloid-derived suppressor cells in T-cell acute lymphoblastic leukemia","volume":"13","author":"Grazioli","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0465","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(05)17706-X","article-title":"Colorectal cancer","volume":"365","author":"Weitz","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114693_bb0470","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3389\/fimmu.2020.01526","article-title":"Myeloid-derived suppressor cells in colorectal Cancer","volume":"11","author":"Sieminska","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0475","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.29800","article-title":"The notch pathway in colorectal cancer","volume":"138","author":"Vinson","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2025.114693_bb0480","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114693_bb0485","doi-asserted-by":"crossref","first-page":"1199273","DOI":"10.3389\/fimmu.2023.1199273","article-title":"MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0490","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/14737140.2022.2011224","article-title":"The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies","volume":"22","author":"Sheida","year":"2022","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.intimp.2025.114693_bb0495","first-page":"43","article-title":"Non-small-cell lung carcinoma: role of the notch signaling pathway","volume":"6","author":"Barse","year":"2015","journal-title":"Lung Cancer (Auckl)."},{"key":"10.1016\/j.intimp.2025.114693_bb0500","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2011.06.005","article-title":"Notch in T-ALL: new players in a complex disease","volume":"32","author":"Koch","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","article-title":"Acute lymphoblastic leukaemia","volume":"10","author":"Pagliaro","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2025.114693_bb0510","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.3390\/ijms252312839","article-title":"Notch inhibitors and BH3 mimetics in T-cell acute lymphoblastic leukemia","volume":"25","author":"Sergio","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114693_bb0515","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/ijms24021383","article-title":"Notch Partners in the Long Journey of T-ALL pathogenesis","volume":"24","author":"Toribio","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114693_bb0520","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.114693_bb0525","article-title":"Notch1 hyperactivity drives ubiquitination of NOX2 and dysfunction of CD8+ regulatory T cells in patients with systemic lupus erythematosus","author":"Yuan","year":"2024","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.intimp.2025.114693_bb0530","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/imm.13570","article-title":"Notch1 signalling controls the differentiation and function of myeloid-derived suppressor cells in systemic lupus erythematosus","volume":"168","author":"Li","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2025.114693_bb0535","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/art.41748","article-title":"Notch-1 and notch-3 mediate hypoxia-induced activation of synovial fibroblasts in rheumatoid arthritis","volume":"73","author":"Chen","year":"2021","journal-title":"Arthritis Rheumatol (Hob NJ)"},{"key":"10.1016\/j.intimp.2025.114693_bb0540","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.114693_bb0545","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/jbmr.3117","article-title":"Targeting notch-activated M1 macrophages attenuates joint tissue damage in a mouse model of inflammatory arthritis","volume":"32","author":"Sun","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2025.114693_bb0550","article-title":"Notch signaling in central nervous system: from cellular development to multiple sclerosis disease","author":"Askari","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.intimp.2025.114693_bb0555","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/eji.201646901","article-title":"Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming","volume":"47","author":"Fern\u00e1ndez","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0560","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.intimp.2025.114693_bb0565","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.it.2005.10.003","article-title":"Understanding the IL-23-IL-17 immune pathway","volume":"27","author":"McKenzie","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0570","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12882-016-0380-x","article-title":"Granulocyte colony-stimulating factor treatment ameliorates lupus nephritis through the expansion of regulatory T cells","volume":"17","author":"Yan","year":"2016","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.intimp.2025.114693_bb0575","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/art.39441","article-title":"Elimination of granulocytic myeloid-derived suppressor cells in lupus-prone mice linked to reactive oxygen species-dependent extracellular trap formation","volume":"68","author":"Vlachou","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2025.114693_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606024","article-title":"Programmed death-ligand 1 expression potentiates the immune modulatory function of myeloid-derived suppressor cells in systemic lupus erythematosus","volume":"12","author":"Park","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0585","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","article-title":"Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients","volume":"34","author":"Sherer","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.intimp.2025.114693_bb0590","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.expneurol.2016.09.012","article-title":"Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis","volume":"286","author":"Casacuberta-Serra","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2025.114693_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2009.04031.x","article-title":"Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis","volume":"159","author":"Wang","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0600","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.41417","article-title":"Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift","volume":"73","author":"Deane","year":"2021","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2025.114693_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.568362","article-title":"The Immunoregulatory role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Yan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0610","doi-asserted-by":"crossref","first-page":"371","DOI":"10.21037\/atm-22-142","article-title":"A narrative review of the role of the notch signaling pathway in rheumatoid arthritis","volume":"10","author":"Zhuang","year":"2022","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.intimp.2025.114693_bb0615","doi-asserted-by":"crossref","first-page":"1272133","DOI":"10.3389\/fimmu.2023.1272133","article-title":"The notch signaling-regulated angiogenesis in rheumatoid arthritis: pathogenic mechanisms and therapeutic potentials","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0620","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2022.14236","article-title":"What is multiple sclerosis?","volume":"328","author":"Marcus","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2025.114693_bb0625","article-title":"Myeloid-derived suppressor cells and multiple sclerosis","author":"Zangh\u00ec","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.intimp.2025.114693_bb0630","first-page":"1329","article-title":"The role of myeloid-derived suppressor cells in multiple sclerosis and its animal model","volume":"15","author":"Jiang","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.intimp.2025.114693_bb0635","article-title":"Signaling mechanisms involved in the regulation of remyelination in multiple sclerosis: a mini review","volume":"101","author":"VNKM","year":"2023","journal-title":"J. Molecular Med. (Berlin, Germany)"},{"key":"10.1016\/j.intimp.2025.114693_bb0640","article-title":"Immunotherapy targeting myeloid-derived suppressor cells (MDSCs) in tumor microenvironment","volume":"11","author":"Gao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.990463","article-title":"Immunotherapy of targeting MDSCs in tumor microenvironment","volume":"13","author":"Sui","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114693_bb0650","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrd4252","article-title":"Therapeutic modulation of Notch signalling--are we there yet?","volume":"13","author":"Andersson","year":"2014","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:57:06Z","timestamp":1778522226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925006836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":130,"alternative-id":["S1567576925006836"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114693","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of notch signaling in regulating myeloid-derived suppressor cells: Implications in Cancer and autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114693"}}